share_log

ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Sees Significant Growth in Short Interest

Defense World ·  Feb 17, 2023 15:32

ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS – Get Rating) was the recipient of a significant growth in short interest during the month of January. As of January 31st, there was short interest totalling 16,700 shares, a growth of 12.1% from the January 15th total of 14,900 shares. Based on an average daily trading volume, of 18,300 shares, the days-to-cover ratio is currently 0.9 days.

Institutional Investors Weigh In On ProShares UltraShort Nasdaq Biotechnology

A number of institutional investors have recently added to or reduced their stakes in the company. IMC Chicago LLC lifted its stake in ProShares UltraShort Nasdaq Biotechnology by 11.1% during the third quarter. IMC Chicago LLC now owns 23,335 shares of the company's stock worth $590,000 after purchasing an additional 2,332 shares during the period. Citadel Advisors LLC lifted its stake in ProShares UltraShort Nasdaq Biotechnology by 234.0% during the second quarter. Citadel Advisors LLC now owns 34,972 shares of the company's stock worth $943,000 after purchasing an additional 24,501 shares during the period. Finally, UBS Group AG lifted its stake in ProShares UltraShort Nasdaq Biotechnology by 236,300.0% during the fourth quarter. UBS Group AG now owns 2,364 shares of the company's stock worth $46,000 after purchasing an additional 2,363 shares during the period.

Get ProShares UltraShort Nasdaq Biotechnology alerts:

ProShares UltraShort Nasdaq Biotechnology Stock Up 2.8 %

Shares of NASDAQ:BIS opened at $19.71 on Friday. The stock's 50-day moving average is $19.01 and its 200-day moving average is $21.16. ProShares UltraShort Nasdaq Biotechnology has a 52-week low of $17.88 and a 52-week high of $35.64.

ProShares UltraShort Nasdaq Biotechnology Company Profile

(Get Rating)

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.

Featured Stories

  • Get a free copy of the StockNews.com research report on ProShares UltraShort Nasdaq Biotechnology (BIS)
  • Bloomin' Brands Blossoms After Raising The Dividend
  • Zebra Technologies: A Reversal Is In Play
  • Zoetis, Pet-Med Specialist, Double-Digit Earnings Growth Ahead
  • The S&P 500: Don't Trust The Wave Of Bullish Sentiment
  • Cisco Systems Is Ready To Run Higher

Receive News & Ratings for ProShares UltraShort Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares UltraShort Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment